17β-Dihydroequilin
From WikiMD's Medical Encyclopedia
What is 17β-Dihydroequilin?[edit]
- 7,8-didehydro-17beta-estradiol is a 3-hydroxy steroid that is obtained by formal dehydrogenation across positions 7 and 8 of 17beta-estradiol. It has a role as a metabolite. It is a 17beta-hydroxy steroid and a 3-hydroxy steroid. It derives from an androstane <ref>17β-Dihydroequilin, ChEBI [1].</ref>.
- IUPAC Name: (9S,13S,14S,17S)-13-methyl-6,9,11,12,14,15,16,17-octahydrocyclopenta[a]phenanthrene-3,17-diol
- InChI: InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16-17,19-20H,2,6-9H2,1H3/t14-,16+,17+,18+/m1/s1
- InChI Key: NLLMJANWPUQQTA-UBDQQSCGSA-N
- Canonical SMILES: CC12CCC3C(=CCC4=C3C=CC(=C4)O)C1CCC2O
- Isomeric SMILES: C[C@]12CC[C@H]3C(=CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O
- Molecular formula: C18H22O2
- Molecular weight: 270.4 g·mol−1
- PubChem CID: 11954027
- Synonyms:
- beta-Dihydroequilin
- 3563-27-7
- UNII-WXG88DST4R
- 7-dehydro-estradiol
- 17Beta-Dihydroequillin
- WXG88DST4R
- 7-dehydro-17beta-estradiol
- ESTRA-1,3,5(10),7-TETRAENE-3,17BETA-DIOL
- CHEMBL121458
- 7,8-didehydro-17beta-estradiol
- CHEBI:62851
- estra-1(10),2,4,7-tetraene-3,17beta-diol
- 7-Dehydroestradiol
- (9S,13S,14S,17S)-13-methyl-6,9,11,12,14,15,16,17-octahydrocyclopenta[a]phenanthrene-3,17-diol
- (9S,13S,14S,17S)-13-Methyl-9,11,12,13,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- NSC 12170
- 17b-Dihydroequilin
- EINECS 222-633-3
- 17-beta-Dihydroequilin
- 17beta-Dihydro Equilin
- SCHEMBL666925
- 7,8-didehydro-17 -estradiol
- DTXSID40871892
- ZINC4428374
- BDBM50423526
- C14485
- W-202466
- Q27132235
- Estra-1,3,5(10),7-tetraene-3,17-diol, (17beta)-
<ref>National Center for Biotechnology Information (2021). PubChem Compound Summary for CID 11954027, 17beta-Dihydroequilin. Retrieved August 5, 2021 from [2].</ref>
References[edit]
| Estrogen receptor modulators | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
